logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Risk factors for antihypertensive medication refill failure by patients under Medicaid managed care.

    Article - En anglais

    Antihypertensive medication noncompliance is common and leads to substantial morbidity for patients and increased health care costs for managed-care organizations.

    A retrospective cohort study using pharmacy prescription profiles to estimate non-compliance was conducted to determine important risk factors for patient noncompliance with antihypertensive therapy for Medicaid enrollees participating in a managed-care plan.

    The pharmacy and claims data for 1395 patients with uncomplicated hypertension who were enrollees of Tennessee Medicaid managed-care program were analyzed to determine the frequency of the enrollees'failure to obtain timely antihypertensive medication refills (hereafter referred to as refill failure) and to identify the predictors of refill failure.

    Overall, refill failure occurred in 33% of 7413 refill opportunities studied, whereas refill failure occurred in 32% of the cases in which medication was dosed once daily and in 35% of the cases in which medication was dosed more than once daily.

    For patients taking alpha-blockers, there was a significantly lower rate of refill failure (11.0%) than for patients taking angiotensin-converting enzyme inhibitors, direct vasodilators, and thiazide diuretics.

    Patients taking calcium channel blockers, had a significantly lower rate of refill failure (38.5%) than for patients taking thiazide diuretics (45.5%). (...)

    Mots-clés Pascal : Antihypertenseur, Chimiothérapie, Traitement, Hypertension artérielle, Homme, Observance médicamenteuse, Approvisionnement, Facteur risque, Etats Unis, Amérique du Nord, Amérique, Appareil circulatoire pathologie, Medicaid

    Mots-clés Pascal anglais : Antihypertensive agent, Chemotherapy, Treatment, Hypertension, Human, Drug compliance, Supply, Risk factor, United States, North America, America, Cardiovascular disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0155935

    Code Inist : 002B02F05. Création : 21/05/1997.